Ranibizumab for Diabetic Macular Edema: Long-term Open-Label Extension of the Phase III Ride and Rise Trials

被引：0
|
作者：
Fung, Anne
Fu, Arthur
Zhang, Jiameng
Ehrlich, Jason S.
机构：
来源：
DIABETES | 2014年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
591-P
引用
收藏
页码：A151 / A152
页数：2
相关论文
共 50 条
  • [11] Durability of diabetic retinopathy improvement and impact of delayed therapy with ranibizumab (RBZ) during the RIDE/RISE open-label extension (OLE)
    Sun, Jennifer K.
    Wang, Pin-wen
    Fung, Anne E.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [12] Effects of intravitreal ranibizumab on retinal hard exudates in patients from the RIDE & RISE diabetic macular edema trials
    Ip, Michael
    Domalpally, Amitha
    Chen, Dafeng
    Ehrlich, Jason
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [13] Influence of Glycosylated Hemoglobin on the Efficacy of Ranibizumab for Diabetic Macular Edema A Post Hoc Analysis of the RIDE/RISE Trials
    Bansal, Alok S.
    Khurana, Rahul N.
    Wieland, Mark R.
    Wang, Pin-Wen
    Van Everen, Sherri A.
    Tuomi, Lisa
    [J]. OPHTHALMOLOGY, 2015, 122 (08) : 1573 - 1579
  • [14] Ranibizumab in Diabetic Macular Edema: A Review of Arterial Thromboembolic Events in Long-Term Controlled Clinical Trials
    Ziemssen, Focke
    Cole, Abosede
    Margaron, Philippe
    Thorburn, Christine
    Watson, Philip
    Hashmonay, Ron
    Bailey, Clare
    [J]. OPHTHALMOLOGICA, 2014, 232 : 18 - 19
  • [15] Outcomes with As-Needed Ranibizumab after Initial Monthly Therapy Long-Term Outcomes of the Phase III RIDE and RISE Trials
    Boyer, David S.
    Nguyen, Quan Dong
    Brown, David M.
    Basu, Karen
    Ehrlich, Jason S.
    [J]. OPHTHALMOLOGY, 2015, 122 (12) : 2504 - +
  • [16] Long-term improvements in vision and diabetic retinopathy achieved and maintained with PRN ranibizumab therapy in the RIDE and RISE trials
    Elman, Michael J.
    Zhang, Jiameng
    Stoilov, Ivaylo
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [17] Long-term effectiveness of ranibizumab for age-related macular degeneration and diabetic macular edema
    Fong, Angie H. C.
    Lai, Timothy Y. Y.
    [J]. CLINICAL INTERVENTIONS IN AGING, 2013, 8 : 467 - 482
  • [18] Long-Term Treatment of Diabetic Neuropathy with Lacosamide: Results from Two Long-Term Open-Label Trials
    Graf, Ronald
    Frye, Wendy
    Simpson, Jeffrey
    Jay, Gary
    Simpson, Karen
    Tzschaschel, Barbara
    Bongardt, Sabine
    Koch, Brigitte
    [J]. NEUROLOGY, 2009, 72 (11) : A212 - A212
  • [19] LONG-TERM PERAMPANEL USE IN OPEN-LABEL EXTENSION STUDIES
    Rektor, Ivan
    Krauss, Gregory L.
    Inoue, Yushi
    Kaneko, Sunao
    Williams, Betsy
    Patten, Anna
    Bibbiani, Francesco
    Laurenza, Antonio
    Wechsler, Robert T.
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2017, 88 : A23 - A23
  • [20] The Association of Aqueous Cytokines with Long-Term Response to Intravitreal Ranibizumab In Diabetic Macular Edema
    Juncal, Verena
    Felfeli, Tina
    Hillier, Roxane
    Ojaimi, Elvis
    Wong, David T.
    Mak, Michael Y. K.
    Berger, Alan R.
    Kohly, Radha P.
    Kertes, Peter
    Forooghian, Farzin
    Boyd, Shelley R.
    Altomare, Filiberto
    Giavedoni, Louis R.
    Nisenbaum, Rosane
    Muni, Rajeev H.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
12345